Company Quick10K Filing
Repro Med Systems
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 39 $86
10-Q 2019-11-06 Quarter: 2019-09-30
10-Q 2019-08-07 Quarter: 2019-06-30
10-Q 2019-05-07 Quarter: 2019-03-31
S-1 2019-02-01 Public Filing
10-K 2019-03-05 Annual: 2018-12-31
10-Q 2018-11-09 Quarter: 2018-09-30
10-Q 2018-08-06 Quarter: 2018-06-30
10-Q 2018-05-07 Quarter: 2018-03-31
10-Q 2017-11-03 Quarter: 2017-09-30
10-Q 2017-08-04 Quarter: 2017-06-30
10-K 2017-05-05 Annual: 2017-02-28
10-Q 2017-01-05 Quarter: 2016-11-30
10-Q 2016-10-07 Quarter: 2016-08-31
10-Q 2016-06-30 Quarter: 2016-05-31
10-K 2016-05-13 Annual: 2016-02-29
10-Q 2016-01-08 Quarter: 2015-11-30
10-Q 2015-10-02 Quarter: 2015-08-31
10-Q 2015-07-10 Quarter: 2015-05-31
10-K 2015-05-08 Annual: 2015-02-28
10-Q 2015-01-14 Quarter: 2014-11-30
10-Q 2014-10-15 Quarter: 2014-08-31
10-Q 2014-07-15 Quarter: 2014-05-31
10-K 2014-05-29 Annual: 2014-02-28
10-Q 2014-01-14 Quarter: 2013-11-30
10-Q 2013-10-15 Quarter: 2013-08-31
10-K 2013-05-29 Annual: 2013-02-28
10-Q 2013-01-14 Quarter: 2012-11-30
10-Q 2012-10-15 Quarter: 2012-08-31
10-Q 2012-07-16 Quarter: 2012-05-31
10-K 2012-05-29 Annual: 2012-02-29
10-Q 2012-01-17 Quarter: 2011-11-30
10-Q 2011-10-17 Quarter: 2011-08-31
10-Q 2011-07-15 Quarter: 2011-05-31
10-K 2011-05-27 Annual: 2011-02-28
10-Q 2011-01-14 Quarter: 2010-11-30
10-Q 2010-10-15 Quarter: 2010-08-31
10-Q 2010-07-15 Quarter: 2010-05-31
10-K 2010-06-01 Annual: 2010-02-28
10-Q 2010-01-14 Quarter: 2009-11-30
8-K 2019-11-12 Other Events
8-K 2019-11-05 Earnings, Exhibits
8-K 2019-10-14 Other Events, Exhibits
8-K 2019-09-30 Officers, Other Events, Exhibits
8-K 2019-08-30 Other Events, Exhibits
8-K 2019-06-28 Other Events
8-K 2019-06-24 Other Events
8-K 2019-05-07 Officers, Other Events, Exhibits
8-K 2019-04-30 Earnings, Exhibits
8-K 2019-04-23 Shareholder Vote
8-K 2019-02-12 Earnings, Exhibits
8-K 2019-02-01 Officers, Other Events, Exhibits
8-K 2018-12-20 Officers, Exhibits
8-K 2018-12-17 Enter Agreement, Officers, Regulation FD, Exhibits
8-K 2018-12-05 Officers, Amend Bylaw, Other Events, Exhibits
8-K 2018-10-24 Regulation FD, Exhibits
8-K 2018-10-23 Earnings, Exhibits
8-K 2018-10-12 Officers, Exhibits
8-K 2018-09-25 Regulation FD
8-K 2018-09-04 Officers, Exhibits
8-K 2018-08-06 Earnings, Exhibits
8-K 2018-07-25 Earnings, Officers, Other Events, Exhibits
8-K 2018-05-03 Amend Bylaw, Exhibits
8-K 2018-04-23 Shareholder Vote
8-K 2018-04-09 Other Events, Exhibits
8-K 2018-02-13 Other Events, Exhibits
8-K 2018-01-17 Other Events

Repro Med Systems Financials

REPR Metrics, Comps, Filings

Annual | Quarterly

Business

REPRO MED SYSTEMS, INC. d/b/a RMS Medical Products (“REPRO MED,” “RMS Medical Products,” “RMS”, the “Company” “our” or “we”), designs, manufactures and markets proprietary and innovative portable medical devices, primarily for the ambulatory infusion market in compliance with the United States Food and Drug Administration (the “FDA”) quality and regulatory system and international standards for quality system management. Our development and marketing focus is primarily concentrated on our mechanical infusion products, the FREEDOM Infusion Systems (which we refer to as the “FREEDOM System” when used with one or more accessories), which include the FREEDOM60® Syringe Driver, the FreedomEdge® Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets™ and RMS Precision Flow Rate Tubing™. The Company incorporated in the State of New York in March 1980.

Our mission is to improve the quality of life of patients around the world through the development and delivery of high quality, innovative and easy to use therapeutic solutions.

We strive to be the best specialty infusion system partner providing a proprietary drug and fluid delivery system for home or alternate site settings where performance, reliability, ease of use and cost effectiveness are driving influencers. Our easy-to-use, lightweight and portable FREEDOM System allows the patient to continue with their daily activities while receiving infusion therapy. The patient experiences optimal therapy delivery using the innovative FREEDOM System with dynamic equilibrium (“DynEqTM”), HIgH-Flo Subcutaneous Safety Needle Sets and RMS Precision Flow Rate Tubing.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Eaco (EACO) 95,530 38% 5.8 10% 92,878 41,688 161,185 61,233 9,432 16,498 96,297
Ammo (POWW) 78,693 -25% -6.2 -34% 46,021 20,194 7,742 -1,934 -15,634 -12,636 78,179
ChoiceOne Financial Services (COFS) 94,691 0% 8.1 1% 663,589 578,963 3,629 0 5,973 9,668 78,117
Invuity (IVTY) 92,683 67% -2.9 -75% 48,729 46,397 40,834 27,211 -36,461 -31,788 93,415
Nobility Homes (NOBH) 92,404 28% 9.0 11% 55,980 7,733 35,568 10,061 5,899 7,955 71,257
Aerkomm (AKOM) 94,280 1% -11.7 -17% 51,277 3,924 1,600 13 -8,941 -7,810 91,529
NCL (NCLC) 90,687 0% 4.3 6% 15,931,783 9,700,324 6,385,388 0 973,844 1,432,690 6,107,285
Humanigen (HGEN) 90,224 -12.4 -1,392% 594 13,260 0 0 -8,268 -7,265 89,996
Fuse Medical (FZMD) 88,479 42% -23.1 -26% 18,157 20,920 15,563 6,576 -4,717 -3,781 87,448
Mattersight (MATR) 89,019 72% -20.5 -39% 28,863 32,587 50,383 36,274 -11,234 -4,549 93,093
Sunnova Energy (NOVA) 709,370 0% -25.1 -4% 2,149,786 1,366,648 71,227 0 -84,176 -70,803 1,775,872
Tropic International (TRPO) 86,438 -136.1 -55% 1,160 3,987 0 0 -635 -635 86,423
Repro Med Systems (REPR) 148,883 64% 210.8 2% 13,717 2,708 21,211 13,620 289 682 143,754
Liberated Syndication (LSYN) 85,599 86% 13.7 7% 42,855 13,372 18,203 15,621 3,195 5,639 77,064
Community Bancorp (CMTV) 84,437 5.3 1% 729,232 661,911 0 0 8,596 15,952 84,437
Helix TCS (HLIX) 65,696 44% -12.3 -12% 74,083 7,816 11,011 4,865 -8,865 -5,311 65,477
Asia Pacific Boiler (PADR) 81,375 -130.3 -15,938% 4 1,600 0 0 -624 -624 81,375
Cannapharmarx (CPMD) 90,342 -12.2 -50% 22,468 9,856 0 0 -11,137 -7,963 97,149
Parkway Acquisition (PKKW) 78,794 3.6 1% 695,180 615,321 0 0 5,434 10,346 37,602
Intrusion (INTZ) 69,323 61% 15.6 62% 6,764 3,494 11,071 6,732 4,169 4,305 67,212

Balance Sheet ($'000)2012-02-292013-02-282014-02-282015-02-282016-02-292017-02-282018-09-302018-12-31
Cash1,7571,9302,2272,5574,2023,3133,6493,739
Accounts Receivable8851,1151,7451,6241,3501,5021,5111,426
Inventory1,1671,1508191,2271,0401,3541,9492,104
PP&E4998762,6661,161997932821859
Assets4,8055,5926,2097,2818,3948,17010,57710,545
Accounts Payable200110247243308772592453
Long-Term Debt10
Liabilities1,2541,2361,0171,0081,2761,4941,4371,584
Stockholders' Equity3,5514,3575,1926,2737,1186,6769,1408,961
Income Statement ($'000)2012-02-292013-02-282014-02-282015-02-282016-02-292017-02-282018-09-302018-12-31
Revenue6,3917,7648,69911,24512,24712,29417,354
Cost of Revenue4,5574,6444,7246,543
Gross Profit6,6887,6037,57010,810
R&D90148218468207237241
SG&A2,6563,5443,8514,7885,9437,7689,096
Tax465312318495255194266
Net Income816726703753783-535911
Cash Flow ($'000)2012-02-292013-02-282014-02-282015-02-282016-02-292017-02-282018-09-302018-12-31
Cash Operating5617859548261,915-3321,480
Cash Investing-339-568-218-745-190-416-1,730
Cash Financing213-43-439249-81-14114